Ikunoshin Kato Selected Research

Messenger RNA (mRNA)

4/2013	Sustained inhibition of HIV-1 replication by conditional expression of the E. coli-derived endoribonuclease MazF in CD4+ T cells.
1/2011	Acquisition of HIV-1 resistance in T lymphocytes using an ACA-specific E. coli mRNA interferase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ikunoshin Kato Research Topics

Disease

3	Neoplasms (Cancer) 01/2012 - 12/2009
2	Infections 04/2013 - 01/2011
1	Carcinogenesis 01/2012
1	Insulin Resistance 01/2012
1	Hypertriglyceridemia 01/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012
1	Chronic Disease (Chronic Diseases) 07/2007
1	Diabetes Mellitus 07/2007
1	Hyperglycemia 07/2007
1	Acinar Cell Carcinoma 10/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2004
1	Inflammation (Inflammations) 07/2002
1	Parasitic Diseases (Parasitic Disease) 07/2002

Drug/Important Bio-Agent (IBA)

2	Messenger RNA (mRNA)IBA 04/2013 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 06/2004 - 07/2002
1	EndoribonucleasesIBA 04/2013
1	FructoseIBA 01/2012
1	OligosaccharidesIBA 01/2012
1	Interferon-gamma (Interferon, gamma)IBA 08/2011
1	AntigensIBA 12/2009
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2009
1	Insulin (Novolin)FDA Link 07/2007
1	Peptides (Polypeptides)IBA 10/2006
1	heparin-binding lectinIBA 07/2002

Therapy/Procedure

1	Immunotherapy 12/2009
1	Therapeutics 12/2009